Financhill
Buy
99

HIMS Quote, Financials, Valuation and Earnings

Last price:
$52.22
Seasonality move :
12.39%
Day range:
$38.21 - $50.56
52-week range:
$11.64 - $72.98
Dividend yield:
0%
P/E ratio:
71.70x
P/S ratio:
6.68x
P/B ratio:
20.16x
Volume:
157.5M
Avg. volume:
34.4M
1-year change:
324.64%
Market cap:
$11.1B
Revenue:
$1.5B
EPS (TTM):
$0.69

Analysts' Opinion

  • Consensus Rating
    Hims & Hers Health has received a consensus rating of Hold. The company's average rating is a Hold based on 3 Buy ratings, 8 Hold ratings, and 1 Sell rating.
  • Price Target Downside
    According to analysts' consensus price target of $44.03, Hims & Hers Health has an estimated downside of -11% from its current price of $49.47.
  • Price Target Upside
    According to analysts, the highest upside price target is $85.00 representing 71.82% upside increase from its current price of $49.47.

Fair Value

  • According to the consensus of 12 analysts, Hims & Hers Health has -11% downside to fair value with a price target of $44.03 per share.

HIMS vs. S&P 500

  • Over the past 5 trading days, Hims & Hers Health has overperformed the S&P 500 by 41.11% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Hims & Hers Health does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Hims & Hers Health has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Hims & Hers Health reported revenues of $586M.

Earnings Growth

  • Hims & Hers Health has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Hims & Hers Health reported earnings per share of $0.20.
Enterprise value:
10.8B
EV / Invested capital:
19.57x
Price / LTM sales:
6.68x
EV / EBIT:
97.82x
EV / Revenue:
6.02x
PEG ratio (5yr expected):
--
EV / Free cash flow:
45.45x
Price / Operating cash flow:
50.42x
Enterprise value / EBITDA:
81.28x
Gross Profit (TTM):
$1.4B
Return On Assets:
26.26%
Net Income Margin (TTM):
9.21%
Return On Equity:
37.84%
Return On Invested Capital:
37.84%
Operating Margin:
9.88%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-03-31 2024-03-31 2025-03-31 2024-03-31 2025-03-31
Income Statement
Revenue $616.4M $959.4M $1.8B $278.2M $586M
Gross Profit $487.4M $790.6M $1.4B $229.1M $430.7M
Operating Income -$63M -$8.3M $109.9M $9.9M $57.9M
EBITDA -$55.2M $2.1M $132.3M $12.9M $66.2M
Diluted EPS -$0.29 -$0.01 $0.69 $0.05 $0.20
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Balance Sheet
Current Assets $340.2M $231.9M $225.5M $261.7M $447M
Total Assets $345.9M $382M $376.3M $448.1M $891.7M
Current Liabilities $19.7M $48.5M $56.3M $93.3M $280.4M
Total Liabilities $53.4M $54.3M $63.6M $103.6M $342.5M
Total Equity $292.5M $327.7M $312.7M $344.5M $549.3M
Total Debt -- -- -- -- --
Trailing 12 Months Fiscal Quarters
Period Ending 2023-03-31 2024-03-31 2025-03-31 2024-03-31 2025-03-31
Cash Flow Statement
Cash Flow Operations $2.4M $89.8M $334.3M $25.8M $109.1M
Cash From Investing $12.1M $5M -$64.9M $13M -$32.8M
Cash From Financing -$14M -$38.4M -$100.6M -$30.3M -$23M
Free Cash Flow -$6.1M $51.9M $236.5M $11.9M $50.1M
HIMS
Sector
Market Cap
$11.1B
$34.5M
Price % of 52-Week High
67.79%
43.57%
Dividend Yield
0%
0%
Shareholder Yield
0.83%
-0.79%
1-Year Price Total Return
324.64%
-42.08%
Beta (5-Year)
1.846
0.660
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $36.63
200-day SMA
Buy
Level $27.03
Bollinger Bands (100)
Buy
Level 25.08 - 42.9
Chaikin Money Flow
Buy
Level 256.7M
20-day SMA
Buy
Level $31.03
Relative Strength Index (RSI14)
Buy
Level 75.16
ADX Line
Buy
Level 22.73
Williams %R
Sell
Level -4.2866
50-day SMA
Buy
Level $33.48
MACD (12, 26)
Buy
Level 2.64
25-day Aroon Oscillator
Buy
Level 84
On Balance Volume
Neutral
Level 557.7M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (16.0727)
Buy
CA Score (Annual)
Level (2.0165)
--
Beneish M-Score (Annual)
Level (--)
Buy
Momentum Score
Level (10)
Buy
Ohlson Score
Level (-2.3964)
Buy
Piotroski F Score (Annual)
Level (6)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (5)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, haircare and more.

Stock Forecast FAQ

In the current month, HIMS has received 3 Buy ratings 8 Hold ratings, and 1 Sell ratings. The HIMS average analyst price target in the past 3 months is $44.03.

  • Where Will Hims & Hers Health Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Hims & Hers Health share price will drop to $44.03 per share over the next 12 months.

  • What Do Analysts Say About Hims & Hers Health?

    Analysts are divided on their view about Hims & Hers Health share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Hims & Hers Health is a Sell and believe this share price will rise from its current level to $25.00.

  • What Is Hims & Hers Health's Price Target?

    The price target for Hims & Hers Health over the next 1-year time period is forecast to be $44.03 according to 12 Wall Street analysts, 3 of them rate the stock a Buy, 1 rates the stock a Sell, and 8 analysts rate the stock a Hold.

  • Is HIMS A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Hims & Hers Health is a Hold. 8 of 12 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of HIMS?

    You can purchase shares of Hims & Hers Health via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Hims & Hers Health shares.

  • What Is The Hims & Hers Health Share Price Today?

    Hims & Hers Health was last trading at $52.22 per share. This represents the most recent stock quote for Hims & Hers Health. Yesterday, Hims & Hers Health closed at $49.47 per share.

  • How To Buy Hims & Hers Health Stock Online?

    In order to purchase Hims & Hers Health stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is it Safe to Invest in Google With OpenAI Threats?
Is it Safe to Invest in Google With OpenAI Threats?

For the last 20 years, Google parent company Alphabet (NASDAQ:GOOG,…

Is Broadcom Stock a Millionaire Maker?
Is Broadcom Stock a Millionaire Maker?

Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…

Is Berkshire The Best Stock to Buy in a Bad Market?
Is Berkshire The Best Stock to Buy in a Bad Market?

Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Buy
60
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Buy
60
RGC alert for May 7

Regencell Bioscience Holdings [RGC] is up 22.52% over the past day.

Buy
77
FARO alert for May 7

Faro Technologies [FARO] is down 0% over the past day.

Buy
53
SRPT alert for May 7

Sarepta Therapeutics [SRPT] is down 21.54% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock